A judge blocked the FDA’s plan to regulate LDTs. What now?
Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test oversight. “This isn’t quite the stake in the heart,’’ said one.
Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test oversight. “This isn’t quite the stake in the heart,’’ said one.
